Stéphane Léonce - Concepedia

Author

Stéphane Léonce

Also Known As

Leonce, S., Leonce, Stéphane, S LEONCE, S Leonce, S Léonce, S. LEONCE, S. Leonce, S. Léonce, Stephane LEONCE, Stephane Leonce

190

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Servier (France)Centre National de la Recherche Scientifique Inserm Université Paris Cité Université Clermont Auvergne

About

Stéphane Léonce is an author at Servier (France) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	57	2.2K
2	Biochemistry	22	39	1.2K
3	Natural Sciences	21	35	1.1K
4	Engineering	2	2	31
5	Health Sciences	1	1	76

Stéphane Léonce

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors Latifa Bouissane, Saı̈d El Kazzouli, Stéphane Léonce, Bioorganic & Medicinal Chemistry Medicinal ChemistryHeterocyclicBenzenesulfonamide DerivativesMedicinePharmacological Agent	2005	129
Synthesis and Cytotoxic and Antitumor Activity of Esters in the 1,2-Dihydroxy-1,2-dihydroacronycine Series Abdelhakim Elomri, Sofia Mitaku, Sylvie Michel, Journal of Medicinal Chemistry	1996	121
Synthesis and in vitro antitumour evaluation of benzothiazole-2-carbonitrile derivatives Valérie Bénéteau, Thierry Besson, Jérôme Guillard, European Journal of Medicinal Chemistry Vitro Antitumour EvaluationDerivativesOrganic ChemistryAnti-cancer AgentPharmacology	1999	91
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle Ying Li, Feng Shan, Jinming Wu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetingG1 PhaseMedicineTumor Targeting	2001	90
Synthesis and Biological Evaluation of Novel Naphthocarbazoles as Potential Anticancer Agents Sylvain Routier, Paul Peixoto, Jean‐Yves Mérour, Journal of Medicinal Chemistry	2005	87
S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab Mike F. Burbridge, Céline Bossard, Carine Saunier, Molecular Cancer Therapeutics Chemoprevention StrategyImmunologyCancer BiologyTumor BiologyReceptor Tyrosine Kinase	2013	86
Multicentric evaluation of the MDR phenotype in leukemia JP Marie, Sylvie Huet, A‐M Faussat, Leukemia Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaPathologyMolecular Diagnostics	1997	85
Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-β-carbolines Marie Laronze, Michel Boisbrun, Stéphane Léonce, Bioorganic & Medicinal Chemistry Medicinal ChemistryNew PyrrolocarbazolesMedicinePharmacologyPharmaceutical Chemistry	2005	83
Novel Benzopyridothiadiazepines as Potential Active Antitumor Agents Nicolas Lebègue, Sebastien Gallet, Nathalie Flouquet, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceNovel BenzopyridothiadiazepinesMedicinePharmacological Agent	2005	82
Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents Vincent Lisowski, Stéphane Léonce, Laurence Kraus‐Berthier, Journal of Medicinal Chemistry	2004	78

Page 1